Skip to main content
Top
Published in: Environmental Health and Preventive Medicine 1/2008

01-01-2008 | Regular Article

Association of serum NO x level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan

Authors: Jun Ueyama, Takaaki Kondo, Ryota Imai, Akiko Kimata, Kanami Yamamoto, Koji Suzuki, Takashi Inoue, Yoshinori Ito, Ken-ichi Miyamoto, Takaaki Hasegawa, Nobuyuki Hamajima

Published in: Environmental Health and Preventive Medicine | Issue 1/2008

Login to get access

Abstract

Objectives

The aim of this study was to determine whether the serum nitrite plus nitrate (NO x ) level correlates with biomarkers that are known components of the metabolic syndrome (MetS).

Methods

Serum NO x levels were measured using a commercial kit in 608 Japanese men and women between the ages of 39 and 85 years. Multivariate adjustments for age, smoking status, alcohol consumption and exercise were made in the analysis of covariance (ANCOVA). The components of the metabolic syndrome were defined based on the following criteria: body mass index (BMI) ≥25.0 kg/m2, glycated hemoglobin (HbA1c) ≥5.6%, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, high-density lipoprotein-cholesterol (HDL-C) ≤1.03 mmol/l for men and ≤1.29 mmol/l for women and triglyceride ≥1.69 mmol/l.

Results

The logarithmically transformed age-adjusted serum NO x (lnNO x ) value was significantly higher in the low HDL-C group (1.76 ± 0.05 μmol/l; p < 0.05) than MetS component groups (1.65 ± 0.01 μmol/l) in men, but no difference was found in women. The means of serum lnNO x after multivariate adjustment were 1.64, 1.65, 1.64, 1.66, and 1.81 μmol/l for 0, 1, 2, 3, and 4–5 MetS components for all subjects, respectively. The results of ANCOVA confirmed that the serum lnNO x level was significantly correlated with the clustering of MetS components in both men and women (p < 0.0001 for trend).

Conclusion

Our results suggest that an increase in the clustering of MetS components was associated with the increase in serum NO levels in our general population.
Literature
1.
go back to reference Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–9.CrossRef Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–9.CrossRef
2.
go back to reference Miyatake N, Kawasaki Y, Nishikawa H, Takenami S, Numata T. Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med. 2006;45:107–8.CrossRef Miyatake N, Kawasaki Y, Nishikawa H, Takenami S, Numata T. Prevalence of metabolic syndrome in Okayama prefecture, Japan. Intern Med. 2006;45:107–8.CrossRef
3.
go back to reference National Cholesterol Educaton Program (NCEP) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III (updated 2004). Circlation 106:3143–221. National Cholesterol Educaton Program (NCEP) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III (updated 2004). Circlation 106:3143–221.
4.
go back to reference Stuehr DJ. Enzymes of the l-arginine to nitric oxide pathway. J Nutr. 2004;134:2748S–51S. Stuehr DJ. Enzymes of the l-arginine to nitric oxide pathway. J Nutr. 2004;134:2748S–51S.
5.
go back to reference Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988;12:365–72. Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988;12:365–72.
6.
go back to reference Binion DG, Fu S, Ramanujam KS, Chai YC, Dweik RA, Drazba JA, et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol. 1998;275:G592–603. Binion DG, Fu S, Ramanujam KS, Chai YC, Dweik RA, Drazba JA, et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol. 1998;275:G592–603.
7.
go back to reference Zuckerbraun BS, Stoyanovsky DA, Sengupta R, Shapiro RA, Ozanich BA, Rao J, et al. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am J Physiol Cell Physiol. 2007;292:C824–31.CrossRef Zuckerbraun BS, Stoyanovsky DA, Sengupta R, Shapiro RA, Ozanich BA, Rao J, et al. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am J Physiol Cell Physiol. 2007;292:C824–31.CrossRef
8.
go back to reference Thippeswamy T, McKay JS, Quinn JP, Morris R. Nitric oxide, a biological double-faced janus – is this good or bad? Histol Histopathol. 2006;21:445–58. Thippeswamy T, McKay JS, Quinn JP, Morris R. Nitric oxide, a biological double-faced janus – is this good or bad? Histol Histopathol. 2006;21:445–58.
9.
go back to reference Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly. 2003;133:360–3. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly. 2003;133:360–3.
10.
go back to reference Tsutsui M, Shimokawa H, Morishita T, Nakashima Y, Yanagihara N. Development of genetically engineered mice lacking all three nitric oxide synthases. J Pharmacol Sci. 2006;102:147–54.CrossRef Tsutsui M, Shimokawa H, Morishita T, Nakashima Y, Yanagihara N. Development of genetically engineered mice lacking all three nitric oxide synthases. J Pharmacol Sci. 2006;102:147–54.CrossRef
11.
go back to reference Konukoglu D, Serin O, Turhan MS. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res. 2006;37:602–6.CrossRef Konukoglu D, Serin O, Turhan MS. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res. 2006;37:602–6.CrossRef
12.
go back to reference Kondo T, Ueyama J, Imai R, Suzuki K, Ito Y. Association of abdominal circumference with serum nitric oxide concentration in healthy population. Environ Health Prev Med. 2006;11:321–5.CrossRef Kondo T, Ueyama J, Imai R, Suzuki K, Ito Y. Association of abdominal circumference with serum nitric oxide concentration in healthy population. Environ Health Prev Med. 2006;11:321–5.CrossRef
13.
go back to reference Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, et al. Metabolic syndrome and urinary cGMP excretion in general population. Atherosclerosis. 2007;190:423–8.CrossRef Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, et al. Metabolic syndrome and urinary cGMP excretion in general population. Atherosclerosis. 2007;190:423–8.CrossRef
14.
go back to reference Kitaichi K, Wang L, Takagi K, Iwase M, Shibata E, Nadai M, et al. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide. Antimicrob Agents Chemother. 1999;43:2697–701. Kitaichi K, Wang L, Takagi K, Iwase M, Shibata E, Nadai M, et al. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide. Antimicrob Agents Chemother. 1999;43:2697–701.
15.
go back to reference Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY, et al. High prevalence of metabolic syndrome in Hong Kong Chinese–comparison of three diagnostic criteria. Diabetes Res Clin Pract. 2005;69:160–8.CrossRef Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY, et al. High prevalence of metabolic syndrome in Hong Kong Chinese–comparison of three diagnostic criteria. Diabetes Res Clin Pract. 2005;69:160–8.CrossRef
16.
go back to reference Clini E, Volterrani M, Pagani M, Bianchi L, Porta R, Gile’ LS, et al. Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies. Int J Cardiol. 2000;73:123–30.CrossRef Clini E, Volterrani M, Pagani M, Bianchi L, Porta R, Gile’ LS, et al. Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies. Int J Cardiol. 2000;73:123–30.CrossRef
17.
go back to reference Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, et al. Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications. J Diabetes Complications. 2001;15:135–43.CrossRef Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, et al. Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications. J Diabetes Complications. 2001;15:135–43.CrossRef
18.
go back to reference Savino A, Pelliccia P, Schiavone C, Primavera A, Tumini S, Mohn A, et al. Serum and urinary nitrites and nitrates and Doppler sonography in children with diabetes. Diabetes Care. 2006;29:2676–81.CrossRef Savino A, Pelliccia P, Schiavone C, Primavera A, Tumini S, Mohn A, et al. Serum and urinary nitrites and nitrates and Doppler sonography in children with diabetes. Diabetes Care. 2006;29:2676–81.CrossRef
19.
go back to reference Rydén M, Elizalde M, van Harmelen V, Ohlund A, Hoffstedt J, Bringman S, et al. Increased expression of eNOS protein in omental versus subcutaneous adipose tissue in obese human subjects. Int J Obes Relat Metab Disord. 2001;25:811–5.CrossRef Rydén M, Elizalde M, van Harmelen V, Ohlund A, Hoffstedt J, Bringman S, et al. Increased expression of eNOS protein in omental versus subcutaneous adipose tissue in obese human subjects. Int J Obes Relat Metab Disord. 2001;25:811–5.CrossRef
20.
go back to reference Osawa M, Hayashi T, Nomura H, Funami J, Miyazaki A, Ignarro LJ, et al. Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin. Nitric Oxide. 2007;16:157–63.CrossRef Osawa M, Hayashi T, Nomura H, Funami J, Miyazaki A, Ignarro LJ, et al. Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin. Nitric Oxide. 2007;16:157–63.CrossRef
21.
go back to reference Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006;98:1352–64.CrossRef Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006;98:1352–64.CrossRef
22.
go back to reference Arteaga E, Villaseca P, Rojas A, Arteaga A, Bianchi M. Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in post-menopausal women. Rev Med Chil. 1998;126:481–7. Arteaga E, Villaseca P, Rojas A, Arteaga A, Bianchi M. Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in post-menopausal women. Rev Med Chil. 1998;126:481–7.
23.
go back to reference Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 1995;91:2982–8. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 1995;91:2982–8.
24.
go back to reference Wever KE, Masereeuw R, Miller DS, Hang XM, Flik G. Endothelin and calciotropic hormones share regulatory pathways in multidrug resistance protein 2 (Mrp2-) mediated transport. Am J Physiol Renal Physiol. 2007;292:F38–46.CrossRef Wever KE, Masereeuw R, Miller DS, Hang XM, Flik G. Endothelin and calciotropic hormones share regulatory pathways in multidrug resistance protein 2 (Mrp2-) mediated transport. Am J Physiol Renal Physiol. 2007;292:F38–46.CrossRef
25.
go back to reference Alessio L, Berlin A, Dell’Orto A, Toffoletto F, Ghezzi I. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health. 1985;5:99–106.CrossRef Alessio L, Berlin A, Dell’Orto A, Toffoletto F, Ghezzi I. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health. 1985;5:99–106.CrossRef
Metadata
Title
Association of serum NO x level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan
Authors
Jun Ueyama
Takaaki Kondo
Ryota Imai
Akiko Kimata
Kanami Yamamoto
Koji Suzuki
Takashi Inoue
Yoshinori Ito
Ken-ichi Miyamoto
Takaaki Hasegawa
Nobuyuki Hamajima
Publication date
01-01-2008
Publisher
Springer Japan
Published in
Environmental Health and Preventive Medicine / Issue 1/2008
Print ISSN: 1342-078X
Electronic ISSN: 1347-4715
DOI
https://doi.org/10.1007/s12199-007-0001-1

Other articles of this Issue 1/2008

Environmental Health and Preventive Medicine 1/2008 Go to the issue